A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas

SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has...

Full description

Bibliographic Details
Main Authors: Lei Dai, Joseph Mugaanyi, Tongyue Zhang, Jingshu Tong, Xingchen Cai, Caide Lu, Changjiang Lu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488775/?tool=EBI
_version_ 1798001420507545600
author Lei Dai
Joseph Mugaanyi
Tongyue Zhang
Jingshu Tong
Xingchen Cai
Caide Lu
Changjiang Lu
author_facet Lei Dai
Joseph Mugaanyi
Tongyue Zhang
Jingshu Tong
Xingchen Cai
Caide Lu
Changjiang Lu
author_sort Lei Dai
collection DOAJ
description SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has been conducted to date. We started by exploring the potential carcinogenic role of SMARCA1 across 33 carcinomas using the cancer genome atlas (TCGA) and the genotype-tissue expression (GTEx) databases. The expression of SMARCA1 was significantly elevated in some tumor types but not in others. There was a distinct relationship between SMARCA1 expression and patient prognosis. S116 phosphorylation levels were up-regulated in both lung adenocarcinoma and uterine corpus endometrial carcinoma. The expression level of SMARCA1 was positively correlated with cancer-associated fibroblasts infiltration in a number of tumors, such as colon adenocarcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma. It was also associated with CD8+ T-cell infiltration in head and neck squamous cell carcinoma and lung adenocarcinoma. Furthermore, SMARCA1 is involved in chromatin remodeling and protein processing-associated mechanisms. Our study presents an initial assessment and illustration of the carcinogenic role of SMARCA1 in different carcinomas.
first_indexed 2024-04-11T11:36:59Z
format Article
id doaj.art-a7241e2b4ac14cc490de4f18e7a08666
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T11:36:59Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-a7241e2b4ac14cc490de4f18e7a086662022-12-22T04:25:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01179A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomasLei DaiJoseph MugaanyiTongyue ZhangJingshu TongXingchen CaiCaide LuChangjiang LuSMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has been conducted to date. We started by exploring the potential carcinogenic role of SMARCA1 across 33 carcinomas using the cancer genome atlas (TCGA) and the genotype-tissue expression (GTEx) databases. The expression of SMARCA1 was significantly elevated in some tumor types but not in others. There was a distinct relationship between SMARCA1 expression and patient prognosis. S116 phosphorylation levels were up-regulated in both lung adenocarcinoma and uterine corpus endometrial carcinoma. The expression level of SMARCA1 was positively correlated with cancer-associated fibroblasts infiltration in a number of tumors, such as colon adenocarcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma. It was also associated with CD8+ T-cell infiltration in head and neck squamous cell carcinoma and lung adenocarcinoma. Furthermore, SMARCA1 is involved in chromatin remodeling and protein processing-associated mechanisms. Our study presents an initial assessment and illustration of the carcinogenic role of SMARCA1 in different carcinomas.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488775/?tool=EBI
spellingShingle Lei Dai
Joseph Mugaanyi
Tongyue Zhang
Jingshu Tong
Xingchen Cai
Caide Lu
Changjiang Lu
A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
PLoS ONE
title A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title_full A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title_fullStr A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title_full_unstemmed A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title_short A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
title_sort pan cancer bioinformatic analysis of the carcinogenic role of smarca1 in human carcinomas
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488775/?tool=EBI
work_keys_str_mv AT leidai apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT josephmugaanyi apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT tongyuezhang apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT jingshutong apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT xingchencai apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT caidelu apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT changjianglu apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT leidai pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT josephmugaanyi pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT tongyuezhang pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT jingshutong pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT xingchencai pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT caidelu pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas
AT changjianglu pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas